Responses
Chronic obstructive pulmonary disease
Original article
Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung
Compose a Response to This Article
Other responses
No responses have been published for this article.